Abattis Bioceuticals Financials
| ATTBF Stock | USD 0.0001 0.00 0.00% |
Abattis |
Understanding current and past Abattis Bioceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Abattis Bioceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Abattis Bioceuticals' assets may result in an increase in income on the income statement.
Abattis Bioceuticals Stock Summary
Abattis Bioceuticals competes with PayPal Holdings, Nasdaq, Choice Hotels, Microsoft, and Vertiv Holdings. Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada. ABATTIS BIOCEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | CA00258G1037 |
| Business Address | 625 Howe Street, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.abattis.com |
| Phone | 808 650 3007 |
| Currency | USD - US Dollar |
Abattis Bioceuticals Key Financial Ratios
There are many critical financial ratios that Abattis Bioceuticals' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Abattis Bioceuticals Corp reports annually and quarterly.| Return On Equity | -0.28 | |||
| Return On Asset | -0.16 | |||
| Number Of Employees | 32 | |||
| Beta | -60.6 | |||
| Z Score | 1.8 |
Abattis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Abattis Bioceuticals's current stock value. Our valuation model uses many indicators to compare Abattis Bioceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abattis Bioceuticals competition to find correlations between indicators driving Abattis Bioceuticals's intrinsic value. More Info.Abattis Bioceuticals Corp is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Abattis Bioceuticals' earnings, one of the primary drivers of an investment's value.Abattis Bioceuticals Corp Systematic Risk
Abattis Bioceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Abattis Bioceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on Abattis Bioceuticals Corp correlated with the market. If Beta is less than 0 Abattis Bioceuticals generally moves in the opposite direction as compared to the market. If Abattis Bioceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Abattis Bioceuticals Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Abattis Bioceuticals is generally in the same direction as the market. If Beta > 1 Abattis Bioceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Abattis Bioceuticals Thematic Clasifications
Abattis Bioceuticals Corp is part of Marijuana investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Entities with exposure to distribution of Marijuana. Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States
This theme covers Entities with exposure to distribution of Marijuana. Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States. Get More Thematic Ideas
| Marijuana | View |
Complementary Tools for Abattis Pink Sheet analysis
When running Abattis Bioceuticals' price analysis, check to measure Abattis Bioceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abattis Bioceuticals is operating at the current time. Most of Abattis Bioceuticals' value examination focuses on studying past and present price action to predict the probability of Abattis Bioceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abattis Bioceuticals' price. Additionally, you may evaluate how the addition of Abattis Bioceuticals to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |